PROJECT
DATA
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN) leverages sophisticated data integration and analytic tools to deliver fit-for-purpose data to its stakeholders. The aggregate data available on this page is intended to provide a high-level overview of our multi-center biorepository; however, patient-level data can be made available to leukodystrophy researchers, pharmaceutical and biotechnology companies, patient advocacy organizations, etc. Please see details below for information on how to request data sets.
![Count by diagnosis_[7].png](https://images.squarespace-cdn.com/content/v1/56d883107c65e424ed7924d3/1742819363333-ON45UWYEB4X1MNVU5WPB/Count+by+diagnosis_%5B7%5D.png)
![Enrollment_count_only[7].png](https://images.squarespace-cdn.com/content/v1/56d883107c65e424ed7924d3/1742819384950-JSUA74D8OTADIY924RK8/Enrollment_count_only%5B7%5D.png)
